SCHEMBL5321065

SCHEMBL5321065

CCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 8/20 0.71
NCOA3 Q9Y6Q9 2/20 0.71
KDM4E B2RXH2 1/20 0.71
TLR4 O00206 1/20 0.71
MEN1 O00255 1/20 0.71
ALDH1A1 P00352 1/20 0.71
LMNA P02545 1/20 0.71
TP53 P04637 1/20 0.71
TYMS P04818 1/20 0.71
GLA P06280 1/20 0.71
POLB P06746 1/20 0.71
HMGB1 P09429 1/20 0.71
MAPT P10636 1/20 0.71
FOLR2 P14207 1/20 0.71
FOLR1 P15328 1/20 0.71
HPGD P15428 1/20 0.71
ALOX15 P16050 1/20 0.71
ALOX12 P18054 1/20 0.71
GART P22102 1/20 0.71
APEX1 P27695 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7165581 0.91 DHFR (0.79) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL5668529 0.91 DHFR (0.65) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL2794954 0.90 DHFR (0.83) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL1073086 0.90 DHFR (0.83) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL7166646 0.88 DHFR (0.75) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL5349920 0.87 DHFR (0.72) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL5402926 0.85 DHFR (0.77) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL5325480 0.84 DHFR (0.77) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL24668562 0.84 DHFR (0.77) DHFRNCOA3KDM4ETLR4MEN1
SCHEMBL15056535 0.84 DHFR (0.77) DHFRNCOA3KDM4ETLR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007098089-A2 TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH METHOTREXATE N-OXIDE AND ANALOGS NOVACEA, INC. (US) 2007-08-30 WO claimed
US-6559149-B1 Lesser side effects without compromise in their efficacy CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-05-06 US claimed
US-6559149-B1 Lesser side effects without compromise in their efficacy CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-05-06 US disclosed
EP-0632038-B1 METHOTREXATE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2001-08-22 EP disclosed
EP-0632038-A1 METHOTREXATE DERIVATIVE Chugai Seiyaku Kabushiki Kaisha (JP) 1995-01-04 EP disclosed